512 — Grand Pharmaceutical Share News
0.000.00%
- HK$15.09bn
- HK$19.44bn
- HK$12.28bn
Brief: Grand Pharmaceutical Says Stc3141 Of Group Approved For Phase Ib Clinical Study For Treatment Of Sepsis In Belgium
Brief: Grand Pharmaceutical Says Profit For Year Attributable HK$2,402.56 Million
Brief: Grand Pharmaceutical Says Entered An Equity Investment Agreement With Itm Isotope Technologies Munich
Brief: Sirtex Medical And Grand Pharmaceutical Group Limited Receive NDA Approval Of Sir-Spheres Y-90 Resin Microspheres In China
Brief: Grand Pharmaceutical Announces A Product Strategic Cooperation With ITM Isotope Technologies Munich SE In Germany
Brief: Grand Pharmaceutical Says Unit Entered Into Huachen Biotech Supply Agreement
Brief: China Grand Pharmaceutical And Healthcare Says Global Innovative Drug Ryaltris Compound Nasal Spray Granted Phase Three Clinical Trial Approval From Nmpa
Brief: China Grand Pharmaceutical And Healthcare Proposed To Stake In Cangzhou Huachen Biotech
Brief: Norges Bank Says Decided To Exclude Four Companies From The Government Pension Fund Global, As Well As To Revoke The Exclusion Of One Company
Brief: China Grand Pharmaceutical And Healthcare Says HY Profit Attributable Hk$1,202.54 Million
Brief: China Grand Pharmaceutical And Healthcare - Entered Strategic Cooperation With Corisma Mcs Systems, Inc
Brief: China Grand Pharmaceutical And Healthcare Says Obtained Commercialization Rights Of An Epinephrine Auto-Injector
Brief: China Grand Pharmaceutical And Healthcare Says Group And Fastwave Medical Inc Entered Agreements
Brief: China Grand Pharma And Healthcare Sees HY Consol Net Profit Attributable To Increase Of Not Less Than 50%
Brief: China Grand Pharmaceutical And Healthcare's Unit To Acquire 10% Equity Interest In Wuhan Grand Hoyo Company
Brief: China Grand Pharmaceutical & Healthcare Says Tadalafil Tablets Granted Drug Registration Certificate
Brief: China Grand Pharma And Healthcare Says Unit Entered Subscription Agreement
Brief: GL Partners Capital Management Cuts Stake In China Grand Pharmaceutical - HKEX Filing
Brief: China Grand Pharmaceutical And Healthcare Reached An Exclusive Product Licensing Agreement